Suppr超能文献

老年人室管膜瘤患者的生存预测因素。

Predictors of survival among older adults with ependymoma.

机构信息

Dan L Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, MS:BCM305, Houston, TX 77030, USA.

出版信息

J Neurooncol. 2012 Mar;107(1):183-9. doi: 10.1007/s11060-011-0730-2. Epub 2011 Sep 28.

Abstract

The biological process of aging encompasses a multitude of complex physiological and lifestyle changes that may alter the way typical prognostic factors affect survival among older ependymoma patients. Because very little is known about the clinical significance of traditional prognostic factors and the magnitude of their effects among older individuals, the purpose of this study was to evaluate the associations between survival and demographic and tumor characteristics among patients with ependymoma who were 60 years of age or older. Using the 1973-2007 dataset from the Surveillance, Epidemiology and End Results (SEER) program, we evaluated the impact of several factors on both overall and ependymoma-specific survival, utilizing multivariable Cox proportional hazards regression. We identified 367 ependymoma cases who were 60 years of age or older at diagnosis and had complete data from SEER. Of these, 19 (5.2%) had anaplastic tumors; all others were low-grade tumors. Age, tumor site, extent of surgery, and tumor histology were found to be significant predictors of ependymoma prognosis. The strongest predictor of poor outcome was supratentorial tumor location (adjusted HR: 6.94, 95% CI: 3.19-15.08, compared to spinal cord tumors). Our study suggests that tumor location, tumor histology, and surgical margin may be key predictors of survival among older ependymoma patients. We believe our study is one of the first to assess the prognostic value of these factors for ependymoma survival exclusively in an older patient population.

摘要

衰老的生物学过程包含了许多复杂的生理和生活方式变化,这些变化可能会改变典型预后因素影响老年室管膜瘤患者生存的方式。由于人们对传统预后因素的临床意义及其在老年人中的影响程度知之甚少,因此本研究旨在评估生存与年龄在 60 岁及以上的室管膜瘤患者的人口统计学和肿瘤特征之间的关系。我们利用 1973-2007 年监测、流行病学和最终结果 (SEER) 计划中的数据集,利用多变量 Cox 比例风险回归评估了几种因素对总体和室管膜瘤特异性生存的影响。我们确定了 367 例年龄在 60 岁及以上且具有 SEER 完整数据的室管膜瘤病例。其中,19 例(5.2%)为间变型肿瘤;其余均为低级别肿瘤。年龄、肿瘤部位、手术范围和肿瘤组织学被认为是室管膜瘤预后的重要预测因素。预后不良的最强预测因素是幕上肿瘤部位(调整后的 HR:6.94,95%CI:3.19-15.08,与脊髓肿瘤相比)。我们的研究表明,肿瘤位置、肿瘤组织学和手术切缘可能是老年室管膜瘤患者生存的关键预测因素。我们相信我们的研究是首次在老年患者群体中专门评估这些因素对室管膜瘤生存预后价值的研究之一。

相似文献

1
Predictors of survival among older adults with ependymoma.老年人室管膜瘤患者的生存预测因素。
J Neurooncol. 2012 Mar;107(1):183-9. doi: 10.1007/s11060-011-0730-2. Epub 2011 Sep 28.
2
Predictors of survival in patients with spinal ependymoma.脊髓室管膜瘤患者生存的预测因素。
Neurol Res. 2015 Jul;37(7):650-5. doi: 10.1179/1743132815Y.0000000041. Epub 2015 Apr 28.
7
Prognostic value of H3K27me3 in children with ependymoma.H3K27me3 在儿童室管膜瘤中的预后价值。
Pediatr Blood Cancer. 2020 Mar;67(3):e28121. doi: 10.1002/pbc.28121. Epub 2019 Dec 18.

引用本文的文献

2
Optimizing outcomes in intracranial ependymoma: a contemporary review.优化颅内室管膜瘤的治疗结果:当代综述
Front Oncol. 2025 Jun 10;15:1617169. doi: 10.3389/fonc.2025.1617169. eCollection 2025.
3
Imaging of supratentorial ependymomas with radio-pathological correlation.幕上室管膜瘤的影像学表现及其与病理的相关性
Explor Target Antitumor Ther. 2024;5(3):766-779. doi: 10.37349/etat.2024.00245. Epub 2024 Jun 27.
4
Do We Need Radiotherapy in Grade II Ependymoma?二级室管膜瘤需要放疗吗?
Front Oncol. 2022 Mar 4;12:800505. doi: 10.3389/fonc.2022.800505. eCollection 2022.

本文引用的文献

3
Ependymomas in adults.成人室管膜瘤。
Curr Neurol Neurosci Rep. 2010 May;10(3):240-7. doi: 10.1007/s11910-010-0109-3.
7
Cancer survivorship and aging.癌症幸存者与衰老
Cancer. 2008 Dec 15;113(12 Suppl):3519-29. doi: 10.1002/cncr.23941.
10
Breast cancer in the elderly.老年乳腺癌
J Clin Oncol. 2007 May 10;25(14):1882-90. doi: 10.1200/JCO.2006.10.2079.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验